Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Queener

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Biochemical Pharmacology|August 15, 1989
Tricyclic 2,4-diaminopyrimidines with broad antifolate activity and the ability to inhibit Pneumocystis carinii growth in cultured human lung fibroblasts in the presence of leucovorinA Rosowsky, J H Freisheim, J B Hynes, et al.
The Journal of Infectious Diseases|April 1, 1992
Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in ratsS F Queener, R A Dean, M S Bartlett, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1991
8-Aminoquinolines from Walter Reed Army Institute for Research for treatment and prophylaxis of Pneumocystis pneumonia in rat modelsM S Bartlett, S F Queener, R R Tidwell, et al.
The New England Journal of Medicine|May 4, 1978
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin DM H Brooks, N H Bell, L Love, et al.
Biochemistry|March 29, 2000
Structural studies on bioactive compounds. 30. Crystal structure and molecular modeling studies on the Pneumocystis carinii dihydrofolate reductase cofactor complex with TAB, a highly selective antifolateV Cody, D Chan, N Galitsky, et al.
The Journal of Infectious Diseases|December 1, 1995
Diagnosis of Pneumocystis carinii pneumonia in AIDS patients by using polymerase chain reactions on serum specimensC Atzori, J J Lu, B Jiang, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 1987
Pneumocystis carinii pneumonia therapy with 9-deazainosine in ratsJ W Smith, M S Bartlett, S F Queener, et al.
Journal of Medicinal Chemistry|March 15, 1996
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluationsJ R Piper, C A Johnson, C A Krauth, et al.
Journal of Medicinal Chemistry|August 28, 1998
Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agentsA Gangjee, A P Vidwans, A Vasudevan, et al.
Journal of Clinical Microbiology|December 1, 1994
Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genesJ J Lu, M S Bartlett, M M Shaw, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Biochemical Pharmacology|August 15, 1989
Tricyclic 2,4-diaminopyrimidines with broad antifolate activity and the ability to inhibit Pneumocystis carinii growth in cultured human lung fibroblasts in the presence of leucovorinA Rosowsky, J H Freisheim, J B Hynes, et al.
The Journal of Infectious Diseases|April 1, 1992
Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in ratsS F Queener, R A Dean, M S Bartlett, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1991
8-Aminoquinolines from Walter Reed Army Institute for Research for treatment and prophylaxis of Pneumocystis pneumonia in rat modelsM S Bartlett, S F Queener, R R Tidwell, et al.
The New England Journal of Medicine|May 4, 1978
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin DM H Brooks, N H Bell, L Love, et al.
Biochemistry|March 29, 2000
Structural studies on bioactive compounds. 30. Crystal structure and molecular modeling studies on the Pneumocystis carinii dihydrofolate reductase cofactor complex with TAB, a highly selective antifolateV Cody, D Chan, N Galitsky, et al.
The Journal of Infectious Diseases|December 1, 1995
Diagnosis of Pneumocystis carinii pneumonia in AIDS patients by using polymerase chain reactions on serum specimensC Atzori, J J Lu, B Jiang, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 1987
Pneumocystis carinii pneumonia therapy with 9-deazainosine in ratsJ W Smith, M S Bartlett, S F Queener, et al.
Journal of Medicinal Chemistry|March 15, 1996
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluationsJ R Piper, C A Johnson, C A Krauth, et al.
Journal of Medicinal Chemistry|August 28, 1998
Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agentsA Gangjee, A P Vidwans, A Vasudevan, et al.
Journal of Clinical Microbiology|December 1, 1994
Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genesJ J Lu, M S Bartlett, M M Shaw, et al.
Pageof 13